Search Results
Apr 09, 2026, 11:37 ET INVESTOR NOTICE: Soleno Therapeutics (SLNO) Investors with Substantial Losses Have Opportunity to Lead Investor Class Action - Hagens Berman
April 9, 2026 /PRNewswire/ -- National shareholder rights law firm Hagens Berman reminds investors in Soleno Therapeutics, Inc. (NASDAQ: SLNO) of the pending securities class action and the upcoming May 5, 2026 lead plaintiff deadline. The firm urges investors who purchased Soleno
More news about: Hagens Berman Sobol Shapiro LLP
Apr 09, 2026, 10:00 ET INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Soleno Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadlines - SLNO
multimedia:https://www.prnewswire.com/news-releases/investor-alert-pomerantz-law-firm-reminds-investors-with-losses-on-their-investment-in-soleno-therapeutics-inc-of-class-action-lawsuit-and-upcoming-deadlines--slno-302737844.htmlSOURCE
More news about: Pomerantz LLP
Apr 08, 2026, 16:20 ET Soleno Therapeutics, Inc. (SLNO) Investors: May 5, 2026, Deadline in Securities Fraud Class Action Lawsuit
Did you buy SLNO common stock between March 26, 2025, and November 4, 2025?Affected Soleno Therapeutics, Inc. Investor SummaryWho: Soleno Therapeutics, Inc. (
More news about: Kessler Topaz Meltzer & Check, LLP
Apr 08, 2026, 12:00 ET Soleno Therapeutics, Inc. (SLNO) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
SLNO).
More news about: Glancy Prongay Wolke & Rotter LLP
Apr 07, 2026, 12:20 ET SLNO SHAREHOLDER UPDATE: Soleno (SLNO) Facing Securities Class Action After DCCR Launch Setback, Share Drop-- Hagens Berman
www.hbsslaw.com/investor-fraud/slnoContact the Firm Now: [email protected] 844-916-0895Soleno Therapeutics, Inc. (SLNO) Securities Class
More news about: Hagens Berman Sobol Shapiro LLP
Apr 07, 2026, 09:00 ET SLNO Shareholder Alert: Investors With Losses May Seek to Lead the Class Action in Soleno Therapeutics, Inc. Securities Lawsuit -- The Gross Law Firm
April 7, 2026 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Soleno Therapeutics, Inc. (NASDAQ: SLNO).
More news about: The Gross Law Firm
Apr 06, 2026, 17:30 ET Are SLNO, FORA, AFBI, MKC Obtaining Fair Deals for their Shareholders?
multimedia:https://www.prnewswire.com/news-releases/are-slno-fora-afbi-mkc-obtaining-fair-deals-for-their-shareholders-302734924.htmlSOURCE
More news about: Halper Sadeh LLP
Apr 06, 2026, 14:00 ET SHAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Soleno Therapeutics, Inc. (NASDAQ: SLNO)
SLNO) related to its sale to Neurocrine Biosciences, Inc. Under the terms of the proposed transaction, Soleno shareholders are expected to receive
More news about: Monteverde & Associates PC
Apr 06, 2026, 10:52 ET Shareholder Alert: The Ademi Firm investigates whether Soleno Therapeutics Inc.'s Transaction with Neurocrine is Fair to Public Shareholders
MILWAUKEE, April 6, 2026 /PRNewswire/ -- Ademi LLP is investigating Soleno (NASDAQ: SLNO) for possible breaches of fiduciary duty and other violations of law in its recently announced transaction with Neurocrine.
More news about: Ademi LLP
Apr 06, 2026, 07:00 ET Neurocrine to Acquire Soleno Therapeutics, Expanding Its Endocrinology and Rare Disease Portfolio
April 6, 2026 /PRNewswire/ -- Neurocrine Biosciences, Inc. (Nasdaq: NBIX) and Soleno Therapeutics, Inc. (Nasdaq: SLNO) today announced that Neurocrine has entered into a definitive agreement to acquire Soleno for $53.00 per share in cash, representing a total transaction
More news about: Neurocrine Biosciences, Inc.
Apr 06, 2026, 04:15 ET Soleno Therapeutics, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - SLNO
SLNO) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Shareholders who purchased shares of SLNO during the class period listed are encouraged
More news about: DJS Law Group LLP
Apr 06, 2026, 03:07 ET SLNO Investors Have Opportunity to Lead Soleno Therapeutics, Inc. Securities Fraud Lawsuit with the Schall Law Firm
SLNO) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange
More news about: The Schall Law Firm
Apr 05, 2026, 19:18 ET SLNO Investors Have Opportunity to Lead Soleno Therapeutics, Inc. Securities Fraud Lawsuit
Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Soleno Therapeutics, Inc. (NASDAQ: SLNO) between March 26, 2025 and November 4, 2025, both dates inclusive (the "Class Period"), of the important May 5, 2026 lead plaintiff deadline.So
More news about: THE ROSEN LAW FIRM, P. A.
Apr 03, 2026, 21:57 ET Soleno Therapeutics Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuit Against Soleno Therapeutics, Inc. - SLNO
Soleno Therapeutics, Inc. ("Soleno" or the "Company") (NasdaqCM: SLNO), if they purchased or otherwise acquired the Company's shares between March 26, 2025 and November 4, 2025, inclusive (the "Class Period"). This action
More news about: ClaimsFiler
Apr 03, 2026, 18:34 ET SLNO INVESTOR ALERT: Soleno (SLNO) Sued After DCCR Launch Setback, Share Drop-- Hagens Berman
www.hbsslaw.com/investor-fraud/slnoContact the Firm Now: [email protected] 844-916-0895Soleno Therapeutics, Inc. (SLNO) Securities
More news about: Hagens Berman Sobol Shapiro LLP
Apr 03, 2026, 15:22 ET Soleno Therapeutics, Inc. (SLNO) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
SLNO). IF YOU ARE AN INVESTOR WHO SUFFERED A LOSS IN SOLENO THERAPEUTICS, INC. (SLNO), CONTACT THE LAW OFFICES OF HOWARD G. SMITH BEFORE MAY 5, 2026 (LEAD PLAINTIFF DEADLINE)
More news about: Law Offices of Howard G. Smith
Apr 03, 2026, 09:06 ET SLNO INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Reminds Soleno Therapeutics (SLNO) Investors of Securities Class Action Deadline on May 5, 2026
LLP, a leading national securities law firm, is investigating potential claims against Soleno Therapeutics, Inc. ("Soleno" or the "Company") (NASDAQ: SLNO) and reminds investors of the May 5, 2026 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed
More news about: Faruqi & Faruqi, LLP
Apr 02, 2026, 18:15 ET Soleno Therapeutics, Inc. Class Action Lawsuit: Investors Face May 5, 2026, Deadline
Did you buy SLNO common stock between March 26, 2025, and November 4, 2025?Affected Soleno Therapeutics, Inc. Investor SummaryWho: Soleno Therapeutics, Inc. (
More news about: Kessler Topaz Meltzer & Check, LLP
Apr 02, 2026, 10:00 ET INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Soleno Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadlines - SLNO
multimedia:https://www.prnewswire.com/news-releases/investor-alert-pomerantz-law-firm-reminds-investors-with-losses-on-their-investment-in-soleno-therapeutics-inc-of-class-action-lawsuit-and-upcoming-deadlines--slno-302732441.htmlSOURCE
More news about: Pomerantz LLP
Apr 01, 2026, 16:24 ET Soleno Therapeutics, Inc. (SLNO) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
SLNO) have opportunity to lead the securities fraud class action lawsuit.
More news about: The Law Offices of Frank R. Cruz, Los Angeles
Apr 01, 2026, 15:43 ET Soleno (SLNO) Sued After DCCR Launch Setback, Share Drop-- Hagens Berman
www.hbsslaw.com/investor-fraud/slnoContact the Firm Now: [email protected] 844-916-0895Soleno Therapeutics, Inc. (SLNO) Securities
More news about: Hagens Berman Sobol Shapiro LLP
Apr 01, 2026, 09:00 ET SLNO Investor Alert: Soleno Therapeutics, Inc. Securities Fraud Lawsuit - Investors With Losses May Seek to Lead the Class Action After Allegedly Conducting Sham Clinical Trials: Levi & Korsinsky
April 1, 2026 /PRNewswire/ -- Levi & Korsinsky, LLP reminds purchasers of Soleno Therapeutics, Inc. (NASDAQ: SLNO) securities of a pending securities class action.
More news about: Levi & Korsinsky, LLP
Mar 31, 2026, 22:37 ET SLNO Investors Have Opportunity to Lead Soleno Therapeutics, Inc. Securities Fraud Lawsuit
Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Soleno Therapeutics, Inc. (NASDAQ: SLNO) between March 26, 2025 and November 4, 2025, both dates inclusive (the "Class Period"), of the important May 5, 2026 lead plaintiff deadline.So
More news about: THE ROSEN LAW FIRM, P. A.
Mar 31, 2026, 09:00 ET SLNO Shareholder Alert: Soleno Therapeutics, Inc. Securities Class Action Lawsuit Investors With Losses May Join -- The Gross Law Firm
March 31, 2026 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Soleno Therapeutics, Inc. (NASDAQ: SLNO).
More news about: The Gross Law Firm
Mar 30, 2026, 16:20 ET Soleno Therapeutics (SLNO) Faces Securities Class Action Amid Hyperphagia Drug Launch Disruptions -- Hagens Berman
SLNO Investors with Losses Encouraged to Contact Hagens BermanSAN FRANCISCO, March 30, 2026 /PRNewswire/ -- A securities class action lawsuit has been filed against Soleno Therapeutics, Inc. (NASDAQ: SLNO) seeking
More news about: Hagens Berman Sobol Shapiro LLP